Amrubicin is effective against small cell carcinoma of the prostate as a second-line chemotherapeutic agent: A case report-Reference-Cited by-同舟云学术

Amrubicin is effective against small cell carcinoma of the prostate as a second-line chemotherapeutic agent: A case report

Published:2019-03-07 Issue:3 Volume:2 Page:133-136
ISSN:2577-171X
Container-title:IJU Case Reports
language:en
Short-container-title:IJU Case Rep

Author:

Maesaka Fumisato¹^ORCID,Nakai Yasushi¹,Tomizawa Mitsuru¹,Owari Takuya¹,Miyake Makito¹,Inoue Takeshi¹,Anai Satoshi¹,Tanaka Nobumichi¹^ORCID,Fujimoto Kiyohide¹

Affiliation:

1. Department of Urology; Nara Medical University; Kashihara Nara Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/iju5.12058/fullpdf

Reference19 articles.

1. Small cell carcinoma of the bladder and prostate;Abbas;Urology,1995

2. Small cell neuroendocrine carcinoma of the prostate: incidence and a report of four cases with an examination of KIT and PDGFRA;Terada;Prostate,2012

3. Treatment outcomes of small cell carcinoma of the prostate: a single-center study;Spiess;Cancer,2007

4. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology “Prostate Cancer” 2016

5. Genitourinary small cell carcinoma: retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center;Asmis;BJU Int.,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer;Anticancer Research;2023-08-30

2. Pharmacology of FDA-Approved Medicines from Actinobacteria;Actinobacteria;2022

3. Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment;Biomedicines;2021-04-12